{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:44:18Z","timestamp":1761540258886},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[1999,8,1]],"date-time":"1999-08-01T00:00:00Z","timestamp":933465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[1999,8]]},"DOI":"10.1006\/cyto.1998.0462","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T15:45:48Z","timestamp":1032191148000},"page":"617-625","source":"Crossref","is-referenced-by-count":10,"title":["THE ROLE OF COMPLEMENT ACTIVATION IN TUMOUR NECROSIS FACTOR-INDUCED LETHAL HEPATITIS"],"prefix":"10.1006","volume":"11","author":[{"given":"Claude","family":"Libert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Wielockx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardo","family":"Grijalba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim","family":"Van Molle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Kremmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey R","family":"Colten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Fiers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Brouckaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/cyto.1998.0462_RF1","series-title":"Biologic Therapy of Cancer","first-page":"295","article-title":"Biologic therapy with TNF: Preclinical studies","author":"Fiers","year":"1995"},{"key":"10.1006\/cyto.1998.0462_RF2","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/ijc.2910380521","article-title":"In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN-gamma, on a syngeneic murine melanoma","volume":"38","author":"Brouckaert","year":"1986","journal-title":"Int J Cancer"},{"key":"10.1006\/cyto.1998.0462_RF3","first-page":"191","article-title":"Clinical experience with high-dose tumor necrosis factor alpha in regional therapy of advanced melanoma","volume":"43","author":"Lejeune","year":"1994","journal-title":"Circ Shock"},{"key":"10.1006\/cyto.1998.0462_RF4","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4049\/jimmunol.154.3.1307","article-title":"Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release","volume":"154","author":"Leist","year":"1995","journal-title":"J Immunol"},{"key":"10.1006\/cyto.1998.0462_RF5","first-page":"1220","article-title":"Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models","volume":"146","author":"Leist","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1006\/cyto.1998.0462_RF6","first-page":"167","article-title":"Tumor necrosis factor and the systemic inflammatory response syndrome","volume":"216","author":"Brouckaert","year":"1996","journal-title":"Curr Topics Microbiol Immunol"},{"key":"10.1006\/cyto.1998.0462_RF7","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/0167-5699(91)90006-F","article-title":"Big MAC attack: Complement proteins cause leaky patches","volume":"12","author":"Esser","year":"1991","journal-title":"Immunol Today"},{"key":"10.1006\/cyto.1998.0462_RF8","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1084\/jem.182.6.1807","article-title":"Complement-mediated regulation of tissue factor activity in endothelium","volume":"182","author":"Saadi","year":"1995","journal-title":"J Exp Med"},{"key":"10.1006\/cyto.1998.0462_RF9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0016-5085(95)90079-9","article-title":"Immunostaining for membrane attack complex of complement is related to cell necrosis in fulminant and acute hepatitis","volume":"108","author":"Pham","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1006\/cyto.1998.0462_RF10","first-page":"139","article-title":"Platelet-activating factor is a mediator in tumor necrosis factor\/galactosamine-induced lethality","volume":"46","author":"Libert","year":"1996","journal-title":"J Inflam"},{"key":"10.1006\/cyto.1998.0462_RF11","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1084\/jem.168.6.2007","article-title":"Tumor necrosis factor\/cachectin. Induction of hemorrhagic necrosis in normal tissue requires the fifth component of complement (C5)","volume":"168","author":"Rothstein","year":"1988","journal-title":"J Exp Med"},{"key":"10.1006\/cyto.1998.0462_RF12","doi-asserted-by":"crossref","first-page":"8720","DOI":"10.1073\/pnas.94.16.8720","article-title":"Abrogation of the alternative complement pathway by targeted deletion of murine factor B","volume":"94","author":"Matsumoto","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1006\/cyto.1998.0462_RF13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4049\/jimmunol.147.2.509","article-title":"Platelet-activating factor produces shock, in vivo complement activation, and tissue injury in mice","volume":"147","author":"Sun","year":"1991","journal-title":"J Immunol"},{"key":"10.1006\/cyto.1998.0462_RF14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev.iy.10.040192.002211","article-title":"The pathophysiology of tumor necrosis factors","author":"Vassalli","year":"1992","journal-title":"Annu Rev Immunol10"},{"key":"10.1006\/cyto.1998.0462_RF15","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1073\/pnas.84.12.4273","article-title":"The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors","volume":"84","author":"Kettelhut","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1006\/cyto.1998.0462_RF16","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1002\/j.1460-2075.1991.tb04978.x","article-title":"Transgenic mice expressing human tumour necrosis factor: A predictive genetic model of arthritis","volume":"10","author":"Keffer","year":"1991","journal-title":"EMBO J"},{"key":"10.1006\/cyto.1998.0462_RF17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2249.1997.291-ce1184.x","article-title":"Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice","volume":"107","author":"Kojouharoff","year":"1997","journal-title":"Clin Expl Immunol"},{"key":"10.1006\/cyto.1998.0462_RF18","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1164\/ajrccm\/143.3.590","article-title":"Plasma levels of tumor necrosis factor in the adult respiratory distress syndrome","volume":"143","author":"Roten","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1006\/cyto.1998.0462_RF19","first-page":"18","article-title":"Inhibition of and sensitization to the lethal effects of tumor necrosis factor","volume":"47","author":"Brouckaert","year":"1996","journal-title":"J Inflam"},{"key":"10.1006\/cyto.1998.0462_RF20","first-page":"335","article-title":"Serum tumor necrosis factor (TNF) in the pathogenesis of clinical hepatic failure of HCV and\/or HBV","volume":"106","author":"Zhang","year":"1993","journal-title":"Chin Med J Engl"},{"key":"10.1006\/cyto.1998.0462_RF21","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1128\/IAI.61.10.4293-4301.1993","article-title":"Activation of the complement system in baboons challenged with live Escherichia coli : Correlation with mortality and evidence for a biphasic activation pattern","volume":"61","author":"de Boer","year":"1993","journal-title":"Infect Immun"},{"key":"10.1006\/cyto.1998.0462_RF22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0167-5699(91)90009-I","article-title":"The role of complement in inflammation and phagocytosis","volume":"12","author":"Frank","year":"1991","journal-title":"Immunol Today"},{"key":"10.1006\/cyto.1998.0462_RF23","first-page":"459","article-title":"Effects of complement activation on platelet-activating factor and eicosanoid synthesis in rat mesangial cells","volume":"120","author":"Lianos","year":"1992","journal-title":"J Lab Clin Med"},{"key":"10.1006\/cyto.1998.0462_RF24","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1128\/IAI.61.4.1474-1481.1993","article-title":"Complement component C5 modulates the systemic tumor necrosis factor response in murine endotoxic shock","volume":"61","author":"Barton","year":"1993","journal-title":"Infect Immun"},{"key":"10.1006\/cyto.1998.0462_RF25","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1016\/S0021-9258(18)53740-6","article-title":"Interaction between apolipoproteins A-I and A-II and the membrane attack complex of complement. Affinity of the apoproteins for polymeric C9","volume":"268","author":"Hamilton","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1006\/cyto.1998.0462_RF26","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.4049\/jimmunol.149.5.1744","article-title":"Role of complement in endotoxin\/platelet-activating factor-induced lung injury","author":"Rabinovici","year":"1992","journal-title":"J Immunol149"},{"key":"10.1006\/cyto.1998.0462_RF27","first-page":"208","article-title":"Ischemic bowel necrosis induced by platelet-activating factor: An experimental model","volume":"13","author":"Hsueh","year":"1988","journal-title":"Methods Achiev Exp Pathol"},{"key":"10.1006\/cyto.1998.0462_RF28","first-page":"G801","article-title":"Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia","volume":"264","author":"Jaeschke","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1006\/cyto.1998.0462_RF29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BFb0027661","article-title":"Galactosamine hepatitis: Key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death","volume":"71","author":"Decker","year":"1974","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"10.1006\/cyto.1998.0462_RF30","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.180.4.1571","article-title":"Protection by \u03b11-acid glycoprotein against tumor necrosis factor-induced lethality","volume":"180","author":"Libert","year":"1994","journal-title":"J Exp Med"},{"key":"10.1006\/cyto.1998.0462_RF31","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.4049\/jimmunol.157.11.5126","article-title":"\u03b11-Antitrypsin inhibits the lethal response to TNF in mice","volume":"157","author":"Libert","year":"1996","journal-title":"J Immunol"},{"key":"10.1006\/cyto.1998.0462_RF32","first-page":"345","article-title":"The role of Kupffer cells in complement activation in D-galactosamine\/lipopolysaccharide-induced hepatic injury of rats","volume":"46","author":"Matsuo","year":"1992","journal-title":"Acta Med Okayama"},{"key":"10.1006\/cyto.1998.0462_RF33","first-page":"23","article-title":"Biosynthesis and genetics of C3","volume":"153","author":"Barnum","year":"1989","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1006\/cyto.1998.0462_RF34","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1089\/hyb.1989.8.615","article-title":"Monoclonal antibodies to complement components without the need of their prior purification. I. Antibodies to mouse C1q","author":"Wasiliu","year":"1989","journal-title":"Hybridoma8"},{"key":"10.1006\/cyto.1998.0462_RF35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0022-1759(83)90425-8","article-title":"Microassay for colorimetric estimation of complement activity in guinea pig, human and mouse serum","volume":"63","author":"Klerx","year":"1983","journal-title":"J Immunol Methods"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466698904628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466698904628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T22:43:59Z","timestamp":1680561839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466698904628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1999,8]]}},"alternative-id":["S1043466698904628"],"URL":"https:\/\/doi.org\/10.1006\/cyto.1998.0462","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[1999,8]]}}}